Chapters
Name
Point-Counterpoint: An Expert-led Discussion on Generalized Myasthenia Gravis (gMG) Treatment Choice
Chapter Time
00:00:00
Chapter Seconds
0
Name
Choosing FcRn Inhibitor Therapy in Generalized Myasthenia Gravis (gMG) and Review of Rozanolixizumab-noli Clinical Data
Chapter Time
00:06:14
Chapter Seconds
374
Name
Choosing Complement Inhibitor Therapy in gMG and Review of Zilucoplan Clinical Data
Chapter Time
00:30:21
Chapter Seconds
1821
Name
Summary
Chapter Time
00:59:10
Chapter Seconds
3550